4.09

0.97% -0.04

Pre-market: 4.17 0.08 +1.96%

Relay Therapeutics Inc (RLAY)

Overview News Price History Option Chain Financials Why RLAY Down? Discussions Forecast

Relay Therapeutics Inc stock is traded at $4.09, with a volume of 1.18M. It is down -0.97% in the last 24 hours and up +15.54% over the past month. Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Previous Close:

$4.13

Open:

$4.13

24h Volume:

1.18M

Relative Volume:

0.64

Market Cap:

$705.16M

Revenue:

$25.55M

Net Income/Loss:

$-341.97M

P/E Ratio:

-1.4607

EPS:

-2.8

Net Cash Flow:

$-304.44M

1W Performance:

+0.74%

1M Performance:

+15.54%

6M Performance:

+16.52%

1Y Performance:

-46.18%

1-Day Range:

$4.05

$4.285

1-Week Range:

$3.885

$4.335

52-Week Range:

$1.775

$8.04

Relay Therapeutics Inc Stock (RLAY) Company Profile

Name

Relay Therapeutics Inc

Sector

Healthcare (1145)

Industry

Biotechnology (643)

Phone

617-370-8837

Address

60 HAMPSHIRE STREET, CAMBRIDGE

Employee

197

Twitter

Next Earnings Date

2025-02-21

Latest SEC Filings

RLAY's Discussions on Twitter

Compare RLAY with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RLAY Relay Therapeutics Inc	4.09	712.06M	25.55M	-341.97M	-304.44M	-2.80
VRTX Vertex Pharmaceuticals Inc	387.15	100.34B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	585.50	60.95B	14.21B	4.46B	3.56B	39.68
ALNY Alnylam Pharmaceuticals Inc	451.73	60.46B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	734.35	46.04B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	332.20	36.02B	3.81B	-644.79M	-669.77M	-6.24

Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-04-25	Resumed	Guggenheim	Buy
Apr-17-25	Initiated	Wells Fargo	Equal Weight
Sep-10-24	Resumed	Goldman	Buy
Sep-10-24	Upgrade	Jefferies	Hold → Buy
Sep-10-24	Downgrade	Oppenheimer	Outperform → Perform
May-10-24	Upgrade	Barclays	Equal Weight → Overweight
Apr-20-23	Upgrade	Jefferies	Underperform → Hold
Apr-19-23	Upgrade	Raymond James	Outperform → Strong Buy
Apr-13-23	Initiated	Raymond James	Outperform
Feb-03-23	Initiated	Oppenheimer	Outperform
Sep-30-22	Initiated	Barclays	Equal Weight
Sep-02-22	Initiated	Stifel	Buy
Jun-06-22	Initiated	Jefferies	Underperform
Feb-01-22	Initiated	Berenberg	Buy
Jul-21-21	Initiated	BofA Securities	Buy
Dec-15-20	Reiterated	H.C. Wainwright	Buy
Dec-08-20	Initiated	JMP Securities	Mkt Outperform
Nov-05-20	Initiated	H.C. Wainwright	Buy
Aug-10-20	Initiated	Cowen	Outperform
Aug-10-20	Initiated	Goldman	Buy
Aug-10-20	Initiated	Guggenheim	Buy
Aug-10-20	Initiated	JP Morgan	Neutral

View All

Relay Therapeutics Inc Stock (RLAY) Latest News

Sep 17, 2025